Immunotherapy Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Request Brochure Request Discount

Report Code: ZMR-1811 | Report Format : | Status : Upcoming |


Global Immunotherapy Drugs Market: Overview

Previously, cancer was treated with chemotherapy, radiation therapy, and sometimes with the help of surgery. Recently, many advanced treatments have emerged in the field of immuno-oncology. The aim of the next generation cancer treatment is to adopt improved techniques of anticancer therapy. Immunotherapy is a biological therapy in which human immunity system is improved to fight against infectious diseases and cancer. This treatment enhances the overall immunity of the body and restricts the growth of the cancer cells. In this treatment, immune cells kill the cancer cells from the body.

Global Immunotherapy Drugs Market: Growth Factors

Rising occurrences of the autoimmune diseases, cancer, and others along with increasing demand for the immunotherapy drugs is anticipated to fuel the immunotherapy drugs market growth. Increasing need for immunotherapy drugs and mAbs is expected to drive the market growth. mAbs possess high resemblance towards the specific disease and areas that require treatment. Immunotherapy drugs are utilized for therapies such as radioimmunotherapy and antibody-directed enzyme prodrug therapy. These antibodies are increasingly used in the development process, thus expecting to enhance the market revenue in the coming years. Materialization of biosimilars is another driving factor for the immunotherapy drugs market.

Global Immunotherapy Drugs Market: Segmentation

The immunotherapy drugs market is classified into therapy area, type of drug, and region. The therapy area is divided into infectious diseases, cancer, autoimmune & inflammatory diseases, and others. The cancer segment is further sub-segmented into the malignant and solid tumor. Depending on the type of drug, the market is fragmented into checkpoint inhibitors, checkpoint inhibitors, monoclonal antibodies, interleukins, adult vaccines, interferons alpha & beta, and others. The adult vaccine is sub-segmented into therapeutic vaccines and preventive vaccines. Region wise, the market is diversified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Global Immunotherapy Drugs Market: Regional Analysis

North America is expected to contribute the largest market share, whereas Asia Pacific will be the fastest growing region for immunotherapy drugs. Favorable government initiatives, availability of technologically advanced health care research framework, personalized medicine, healthy R&D investment, and development of next generation sequencing are some of the key factors responsible for the growth of immunotherapy drugs in North America. Low cost of manufacturing coupled with an acceptable regulatory scenario in this region may give rise to the market growth. Prosperous middle class willing to spend on quality healthcare products along with the presence of a vast pool of geriatric population in Asia Pacific region anticipate emerging as a most promising investment destination for the immunotherapy drugs. High disposable income, development of health care infrastructure, largely untapped market base, the rise in health and hygiene related awareness, and economic development in Asia Pacific region is expected to augment the immunotherapy drugs market growth in future.

Global Immunotherapy Drugs Market: Competitive Players

Major market players in the global immunotherapy drugs market include F. Hoffmann-La Roche, Merck, AbbVie, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, Alder Biopharmaceuticals, ChemoCentryx, Boehringer Ingelheim, and Amgen. Other prominent players include Argos Therapeutics, Agenus, CTI BioPharma, AVAX Technologies, ADC Therapeutics, Agensys, Biothera, Biogen, Aduro Biotech, Acorda Therapeutics, Eli Lilly, Advaxis, Coherus BioSciences, and Bavarian Nordic.

Global Immunotherapy Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Report Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Pharmaceutical Excipients Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3599.00 | Report Code: ZMR-2947 | Report Format:

Global Pharmaceutical Excipients Market: Overview An inactive substance, acting as a carrier with no medicinal properties that play a role in aiding characteristics which help in the formation of a tablet is known as excipients. It basically involves all the substance (except active pharmaceutic...Read More

Bipolar Disorder Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2940 | Report Format:

Global Bipolar Disorder Market: Overview Bipolar disorder is usually recognized as manic depression, it is a kind of mental illness which is mainly categorized by mood swings. Mood episodes are basically of two types: depressive and manic episodes. The changes or transformation in the mental con...Read More

Breakthrough Therapy (BT) Designation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2939 | Report Format:

Global Breakthrough Therapy (BT) Designation Market: Overview The breakthrough designation therapy is granted to medicines/drugs that bring about considerable betterment in syndrome conditions as compared to existing therapies at the time of preliminary stages of medical trials for the healing o...Read More

Hemophilia Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3999.00 | Report Code: ZMR-2935 | Report Format:

Global Hemophilia Market: Overview Hemophilia is basically genetic bleeding syndrome caused owing to shortage or missing protein required for clotting, owing to which blood clotting does not take place. The episodes of bleeding majorly depend on the severity of hemophilia issue. There are two ma...Read More

Intravenous Immunoglobulin (IVIG) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3999.00 | Report Code: ZMR-2934 | Report Format:

Global Intravenous Immunoglobulin (IVIG) Market: Overview Immunoglobulins (IGs) are basically glycoproteins generated in the blood plasma in reaction to the antigens, which are entirely foreign to the host system. They are extremely complex entities as well as explicit in their action. They are ...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.